Perspective Therapeutics, Inc. (CATX) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 38 transactions totaling $58.5M, demonstrating a bullish sentiment with $58.5M in net insider flow. The most recent transaction on Nov 13, 2025 involved a purchase of 11,000 shares valued at $22.3K.
No significant insider buying has been recorded for CATX in the recent period.
No significant insider selling has been recorded for CATX in the recent period.
Based on recent SEC filings, insider sentiment for CATX is bullish with an Insider Alignment Score of 100/100 and a net flow of $58.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Perspective Therapeutics, Inc. (CATX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading CATX stock, having executed 38 transactions in the past 90 days. The most active insider is Alpha Therapy, Llc Lantheus (Executive), who has made 1 transactions totaling $57.4M.
Get notified when executives and directors at CATX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Robert Hunt Jonathan | Executive | Purchase | 11,000 | $2.03 | $22.3K | |
| Nov 12, 2025 | F. Williamson Robert III | Executive | Purchase | 9,498 | $2.10 | $19.9K | |
| Jun 17, 2024 | Robert Hunt Jonathan | Executive | Purchase | 1,800 | $9.82 | $17.7K | |
| Jun 14, 2024 | A. Woods Lori | Executive | Purchase | 83 | $10.80 | $896 | |
| Jun 14, 2024 | A. Woods Lori | Executive | Purchase | 4,504 | $10.90 | $49.1K | |
| Jun 13, 2024 | M. Spoor Johan | Executive | Purchase | 100,000 | $1.17 | $117.0K | |
| Jun 3, 2024 | A. Woods Lori | Executive | Purchase | 34,246 | $1.46 | $50.0K | |
| May 31, 2024 | F. Williamson Robert III | Executive | Purchase | 55,000 | $1.38 | $75.9K | |
| May 31, 2024 | Robert Hunt Jonathan | Executive | Purchase | 12,000 | $1.40 | $16.8K | |
| May 31, 2024 | Robert Hunt Jonathan | Executive | Purchase | 13,006 | $1.40 | $18.2K | |
| May 29, 2024 | F. Williamson Robert III | Executive | Purchase | 18,656 | $1.34 | $25.0K | |
| May 29, 2024 | F. Williamson Robert III | Executive | Purchase | 11,375 | $1.32 | $15.0K | |
| Apr 23, 2024 | John Austin Mark | Executive | Option Exercise | 30,000 | $0.36 | $10.8K | |
| Mar 6, 2024 | Therapy, Llc Lantheus Alpha | Executive | Purchase | 60,431,039 | $0.95 | $57.4M | Large10b5-1 |
| Jan 30, 2024 | F. Williamson Robert III | Executive | Purchase | 3,500 | $0.70 | $2.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 37 | $58.5M | 100.0% |
Exercise(M) | 1 | $10.8K | 0.0% |
Insiders at Perspective Therapeutics, Inc. are accumulating shares at an accelerated pace. With 7 insiders making 38 transactions totaling $58.5M in purchases versus $0 in sales, the net buying activity of $58.5M signals strong executive confidence. Alpha Therapy, Llc Lantheus (Executive) leads the buying activity with $57.4M in transactions across all time.